价格

ETHYPHARM

HALL, Saint-Cloud, Île-de-France, 法国

概览

试验阶段分布

阶段

试验数

占比

3 期

66.7%

试验状态分布

已完成

66.7%

招募中

33.3%

药物批准

按机构分类的批准

PHILIPPINES

Philippines FDA

药物批准

SFDA

Saudi Food and Drug Authority

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

EP-Feno tablet 145 mg

NPRA

2026-03-27

Lorpitan Trio (Aprepitant 125mg Hard Capsule)

NPRA

2025-11-28

Lorpitan Trio (Aprepitant 80mg Hard Capsule)

NPRA

2025-11-28

Fenofibrate Ethypharm

MORFINA ETHYPHARM 20 MG/ML SOLUCION INYECTABLE

CIMA_AEMPS

2019-11-25

MORFINA ETHYPHARM 10 MG/ML SOLUCION INYECTABLE EFG

CIMA_AEMPS

2019-11-25

LINEVERO 10 MG COMPRIMIDOS EFG

CIMA_AEMPS

2019-09-19

资讯

暂无资讯文章

返回机构列表

ETHYPHARM

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（3）

Baclocur® Post-Authorisation Safety Study in Real-life Settings in France

Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients

Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer

药物批准

按机构分类的批准

近期批准

资讯